Effects of exogenous adrenaline and noradrenaline on vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man. 1984

K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten

The effects of adrenaline and noradrenaline on vascular postsynaptic alpha 1- and alpha 2-adrenoceptors were investigated in six healthy volunteers. The catecholamines were infused intra-arterially, in three cumulative doses, together with a continuous infusion of saline, doxazosin (alpha 1-selective antagonist), yohimbine (alpha 2-selective antagonist) or the combination of the two antagonists, and changes in forearm blood flow were measured by plethysmography. beta-adrenoceptor mediated effects of the catecholamines were prevented by concomitant intra-arterial infusion of propranolol. Adrenaline and noradrenaline reduced forearm blood flow dose-dependently and to the same extent. The vasoconstrictive effect of adrenaline and of noradrenaline was significantly reduced by doxazosin and by yohimbine, and, to a greater extent, by the combination of doxazosin and yohimbine. The magnitude of these reductions were approximately the same for adrenaline and noradrenaline. No changes in heart rate or blood pressure were observed during the infusions. It is concluded that exogenous adrenaline and noradrenaline produce vasoconstriction in the vasculature of the human forearm by stimulation of both postsynaptic alpha 1- and alpha 2-adrenoceptors.

UI MeSH Term Description Entries
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005542 Forearm Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST. Antebrachium,Antebrachiums,Forearms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
May 1979, British journal of pharmacology,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
November 1984, Federation proceedings,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
November 1987, Archives internationales de pharmacodynamie et de therapie,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
December 1987, Endocrinologia experimentalis,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
December 1984, British journal of clinical pharmacology,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
November 1986, British journal of pharmacology,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
January 1988, Pharmacology & toxicology,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
October 1982, European journal of pharmacology,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
February 1985, European journal of pharmacology,
K Jie, and P van Brummelen, and P Vermey, and P B Timmermans, and P A van Zwieten
September 1980, European journal of pharmacology,
Copied contents to your clipboard!